Mesothelial cells in suspension expose an enriched integrin repertoire capable of capturing soluble fibronectin and laminin.
Pleural cavities are lined by a polarized monolayer of mesothelial cells (MC). During pleuritis, MC are shed into effusions, and pleural obstruction may occur. Integrins are cell surface receptors mediating interactions with extracellular matrix (ECM) proteins. The distribution of beta 1-, beta 3-, beta 4-integrins and fibronectin and laminin in normal and chronically inflamed pleura and in/on MC from pleural effusions was examined by immunomorphology and flow cytometry. Adhesion assays of MC to fibronectin and laminin were performed. In situ, resting MC expressed beta 1-, beta 3-, and beta 4-, and alpha v-subunits. Activated MC were beta 1- and alpha v-positive and also expressed alpha 3 and alpha 6; beta 4 was confined to the basal surface of MC; beta 3 was absent. Floating MC from effusions neoexpressed alpha 5 and reexpressed beta 3. In vitro, MC surface expressed beta 1, beta 3, alpha 3, alpha 5, alpha 6, alpha v, and also alpha 1 and alpha 2. In normal pleura, fibronectin and laminin were components of the basement membrane. In pleuritis, the basement membrane was desintegrated. Instead, newly formed fibronectin/laminin containing fibrils extended into the submesothelial connective tissue. Floating MC freshly isolated from effusions carried fibronectin and laminin on their surface and showed specific binding to these ECM proteins. Binding was blocked by anti-beta 1 or anti-alpha 5 and anti-alpha 6 antibodies, respectively. MC incubated with fibronectin showed a clear shift to the S phase, while laminin had no effect. In conclusion, activated and detached MC progressively enrich their integrin repertoire. By capturing soluble fibronectin and laminin and by matrix-mediated bridging, readhering MC may contribute to pleural obstruction. Further, soluble fibronectin bound to alpha 5 beta 1 might be life-sustaining for floating MC by driving cells into cell cycle.
Institute of Pathology, Ulm University, Ulm, Germany. thomas.barth@medizin.uni-ulm.de
Thomas F E
TF
Barth
Nadia
N
Rinaldi
Silke
S
Brüderlein
Gunhild
G
Mechtersheimer
Jörn
J
Sträter
Peter
P
Altevogt
Peter
P
Möller
D015703:Antigens, CD / Q000096:biosynthesis; D002448:Cell Adhesion; D002453:Cell Cycle; D002478:Cells, Cultured; D004848:Epithelium / Q000378:metabolism*; D005353:Fibronectins / Q000378:metabolism*; D005434:Flow Cytometry; D006801:Humans; D007150:Immunohistochemistry; D039564:Integrin alphaV; D019012:Integrin beta1 / Q000096:biosynthesis; D039661:Integrin beta3; D039663:Integrin beta4; D016023:Integrins / Q000096:biosynthesis*; D007797:Laminin / Q000378:metabolism*; D008168:Lung / Q000473:pathology; D010980:Platelet Membrane Glycoproteins / Q000096:biosynthesis; D010995:Pleural Diseases / Q000378:metabolism
D015703:Antigens, CD; D005353:Fibronectins; D039564:Integrin alphaV; D019012:Integrin beta1; D039661:Integrin beta3; D039663:Integrin beta4; D016023:Integrins; D007797:Laminin; D010980:Platelet Membrane Glycoproteins